SCHEMBL21698575

SCHEMBL21698575

BC(B)(O)N(Cc1ccc(/C(Cl)=N/O)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ HDAC3 O15379 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ NCOR2 Q9Y618 1/20 0.37
▸ GPR119 Q8TDV5 4/20 0.35
▸ LMNA P02545 1/20 0.31
▸ AKT1 P31749 2/20 0.30
▸ KDM1A O60341 2/20 0.30
▸ HDAC8 Q9BY41 1/20 0.30
▸ HDAC6 Q9UBN7 1/20 0.30
▸ HSD11B1 P28845 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20746766 0.91 HDAC3 (0.38) HDAC3HDAC1HDAC2NCOR2GPR119
SCHEMBL14838574 0.82 ALDH1A1 (0.40) HDAC3HDAC1HDAC2NCOR2GPR119
SCHEMBL14829667 0.82 ALDH1A1 (0.40) HDAC3HDAC1HDAC2NCOR2GPR119
SCHEMBL21698542 0.80 GPR119 (0.40) HDAC3HDAC1HDAC2NCOR2GPR119
SCHEMBL24038574 0.80 HDAC1 (0.48) HDAC3HDAC1HDAC2NCOR2GPR119
SCHEMBL14829732 0.79 HDAC1 (0.38) HDAC3HDAC1HDAC2NCOR2GPR119
SCHEMBL15120098 0.79 HDAC1 (0.38) HDAC3HDAC1HDAC2NCOR2GPR119
SCHEMBL21300012 0.77 — —
SCHEMBL21299982 0.76 LOXL2 (0.44) HDAC3HDAC1HDAC2NCOR2HDAC6
SCHEMBL15120076 0.75 HDAC3 (0.34) HDAC3HDAC1HDAC2NCOR2GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3878851-A1 PROCESS FOR MAKING COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2021-09-15 — — EP disclosed
EP-3608316-A1 DEUTERATED DERIVATIVES OF AN INHIBITOR OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2020-02-12 — — EP disclosed
Send feedback